Mistral Therapeutics
Mistral Therapeutics operates as a biotechnology company developing medicines to treat fibrosis
About Mistral Therapeutics
Mistral Therapeutics was a venture-backed biopharmaceutical company established in 2011, with its base of operations in San Diego, California.
The firm's strategic focus was on the development of therapeutic agents aimed at treating fibrotic diseases. By targeting this area, the company intended to address the needs of patients suffering from these specific health disorders, with the goal of providing treatments that could be initiated more quickly and offer a higher probability of success.
From a financial perspective, Mistral Therapeutics operated within the life sciences and drug discovery sectors. The company successfully secured early-stage venture capital, closing a Series A financing round in June 2014 that raised $10.5 million. This funding was critical for its initial startup and research phases. The company also progressed to a Series B financing stage.
The company, which was previously known as Inception 1, ceased operations as of December 2, 2019.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2011
- Headquarters
- San Diego, United States
- Open positions
- None listed
- Dealroom signal
- 16.0/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Client focus
- B2B
- Links
- Website
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Jul 2018 | $26M | $104M | Undisclosed | — |
| EARLY VCEquity / VC | Jul 2014 | $11M | $42M | Undisclosed | — |
Growth signals
Latest recorded traffic for Mistral Therapeutics is 0 monthly website visits.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Mistral Therapeutics in the San Diego ecosystem
The Mistral Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Mistral Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Mistral Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








